Search research articles
Contact Us
Filters
Showing results (41-50 of 118) with videos related to
Page
of 12
Sort By:
Pharmacology, Biochemistry, and Behavior
|
October 9, 2024
Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien-Yuan Lane, Shi-Heng Wang, Chieh-Hsin Lin
The International Journal of Neuropsychopharmacology
|
January 13, 2022
Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial
Chieh-Hsin Lin, Shi-Heng Wang, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
April 6, 2011
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin, Hsien-Yuan Lane, Guochuan E Tsai
International Journal of Molecular Sciences
|
September 28, 2021
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
International Journal of Molecular Sciences
|
October 23, 2021
d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
International Journal of Molecular Sciences
|
August 27, 2021
From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
August 19, 2019
D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment
Chieh-Hsin Lin, Hui-Ting Yang, Hsien-Yuan Lane
Psychiatry and Clinical Neurosciences
|
November 6, 2022
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien-Yuan Lane, Shi-Heng Wang, Chieh-Hsin Lin
Frontiers in Psychiatry
|
April 20, 2018
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease
Wen-Yu Hsu, Hsien-Yuan Lane, Chieh-Hsin Lin
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
August 5, 2016
Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
Chien-Yu Chen, Hsien-Yuan Lane, Chieh-Hsin Lin
Page
of 12
Search research articles
Search
Showing results (41-50 of 118) with videos related to
Sort By:
Page
of 12
Pharmacology, Biochemistry, and Behavior
|
October 9, 2024
Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien-Yuan Lane, Shi-Heng Wang, Chieh-Hsin Lin
The International Journal of Neuropsychopharmacology
|
January 13, 2022
Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial
Chieh-Hsin Lin, Shi-Heng Wang, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
April 6, 2011
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin, Hsien-Yuan Lane, Guochuan E Tsai
International Journal of Molecular Sciences
|
September 28, 2021
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
Chung-Chieh Hung, Chieh-Hsin Lin, Hsien-Yuan Lane
International Journal of Molecular Sciences
|
October 23, 2021
d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
International Journal of Molecular Sciences
|
August 27, 2021
From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy
Yu-Jung Cheng, Chieh-Hsin Lin, Hsien-Yuan Lane
Pharmacology, Biochemistry, and Behavior
|
August 19, 2019
D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment
Chieh-Hsin Lin, Hui-Ting Yang, Hsien-Yuan Lane
Psychiatry and Clinical Neurosciences
|
November 6, 2022
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien-Yuan Lane, Shi-Heng Wang, Chieh-Hsin Lin
Frontiers in Psychiatry
|
April 20, 2018
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease
Wen-Yu Hsu, Hsien-Yuan Lane, Chieh-Hsin Lin
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
August 5, 2016
Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
Chien-Yu Chen, Hsien-Yuan Lane, Chieh-Hsin Lin
Page
of 12